中文无码一区二区不卡av,久久人人爽人人爽人人av,一本色道久久hezyo无码 ,国产另类ts人妖一区二区

首頁 >> 產(chǎn)品展示 >> 生化試劑 >> 海外試劑代購 >> MatriksBiotek品牌產(chǎn)品列表介紹

MatriksBiotek品牌產(chǎn)品列表介紹

簡要描述:MatriksBiotek品牌產(chǎn)品列表介紹
MatrikSBIotek®Co。,作為一家成立于2002年的生物技術(shù)公司,正在慶祝其15年的業(yè)務(wù)。 以生產(chǎn)為導(dǎo)向的公司致力于研究和創(chuàng)新免疫,分子和工具,將有助于健康。 在市場上使用生物藥物測試SHIKARI®ELISA試劑盒,自從在市場上*生產(chǎn)和商業(yè)化以來已有10年的歷史。

  • 產(chǎn)品型號:
  • 廠商性質(zhì):經(jīng)銷商
  • 更新時間:2019-04-23
  • 訪  問  量:1160
詳細(xì)資料

MatriksBiotek品牌產(chǎn)品列表介紹


MatrikSBIotek®Co。,作為一家成立于2002年的生物技術(shù)公司,正在慶祝其15年的業(yè)務(wù)。 以生產(chǎn)為導(dǎo)向的公司致力于研究和創(chuàng)新免疫,分子和工具,將有助于健康。 在市場上使用生物藥物測試SHIKARI®ELISA試劑盒,自從在市場上*生產(chǎn)和商業(yè)化以來已有10年的歷史。 

在36個國家和30多家制藥公司充滿信心地使用和/或使用我們的產(chǎn)品。 生物制劑(主要是人源化重組單克隆抗體)在某些疾病中作為藥物的使用引起每個單獨治療的人的有效性問題。 監(jiān)測藥物水平和抗體在管理對重組和/或人源化抗體的反應(yīng)缺乏或喪失方面發(fā)揮著新的作用(即,確認(rèn)治療持續(xù),劑量調(diào)整,提供轉(zhuǎn)換為另一種藥劑或不同藥劑的理由 一類生物制劑)。

 

MatriksBiotek品牌產(chǎn)品列表介紹

 

MatrikSBIotek介紹

Reference CodeProduct NameDescription
TR-Q-INFLIXIv2Q-INFLIXIEnzyme immunoassay for the quantitative determination of free Infliximab (Remicade®) in serum and plasma
TR-ATIv5Q-ATIEnzyme immunoassay for the qualitative determination of specific antibodies to infliximab in human serum and plasma with confirmation
TR-ATIv6Q-ATIEnzyme immunoassay for the quantitative determination of specific antibodies to infliximab in human serum and plasma with confirmation
TR-ATIv8Q-ATI DUOEnzyme immunoassay for the semi-quantitative determination (screening) of total and free antibodies to infliximab (Remicade®) in serum and plasma.
TR-ADAv1Q-ADAEnzyme immunoassay for the quantitative determination of free adalimumab (Humira®) in serum and plasma
TR-AADAv1S-ATAEnzyme immunoassay for the qualitative determination of antibodies to adalimumab (Humira®) in serum and plasma with confirmation
TR-AADAv2S-ATAEnzyme immunoassay for the quantitative determination of antibodies to adalimumab (Humira®) in serum and plasma with confirmation
TR-AADAv4S-ATA DUOEnzyme immunoassay for the semi-quantitative determination (screening) of total and free antibodies to adalimumab (Humira®) in serum and plasma
TR-ETAv2Q-ETAEnzyme immunoassay for the quantitative determination of free Etanercept (Enbrel) in serum and plasma
TR-AETAv2S-ATEEnzyme immunoassay for the qualitative determination of antibodies to etanercept in serum and plasma
TR-BEVAv2Q-BEVAEnzyme immunoassay for the quantitative determination of Bevacizumab (Avastin®) in serum and plasma
TR-ABEVAv1S-ATBEnzyme immunoassay for the qualitative determination of antibodies to Bevacizumab (Avastin®) in serum and plasma
TR-ABEVAv2S-ATBEnzyme immunoassay for the quantitative determination of antibodies to Bevacizumab (Avastin®) in serum and plasma
TR-RTXv2Q-RITUXEnzyme immunoassay for the quantitative determination of antibodies to Rituximab® (Rituxan®, Mabthera®) in serum and plasma
TR-ARTXv1S-ATREnzyme immunoassay for the qualitative determination of antibodies to Rituximab® (Rituxan®, Mabthera®) in serum and plasma
TR-ARTXv2S-ATREnzyme immunoassay for the quantitative determination of antibodies to Rituximab® (Rituxan®, Mabthera®) in serum and plasma
TR-TRASv2Q-TRASEnzyme immunoassay for the quantitative determination of Trastuzumab (Herceptin®, Herclon®)
TR-ATRASv1S-ATTEnzyme immunoassay for the qualitative determination of antibodies to Trastuzumab (Herceptin®, Herclon®) in serum and plasma
TR-ATRASv2S-ATTEnzyme immunoassay for the quantitative determination of antibodies to Trastuzumab (Herceptin®, Herclon®) in serum and plasma
TR-GOLv1Q-GOLEnzyme immunoassay for the quantitative determination of free Golimumab (Simponi®) in serum and plasma.
TR-ATGv1S-ATGEnzyme immunoassay for the qualitative determination of antibodies to Golimumab in serum and plasma.
TR-CETv1Q-CETEnzyme immunoassay for the quantitative determination of free Cetuximab (Erbitux®) in serum and plasma.
TR-ATCv1S-ATCEnzyme immunoassay for the qualitative determination of antibodies to cetuximab in serum and plasma.
TR-ATCv2S-ATCEnzyme immunoassay for the quantitative determination of antibodies to cetuximab in serum and plasma.
TR-REMSv1Q-REMSEnzyme immunoassay for the quantitative determination of free Infliximab (Remsima®) in serum and plasma.
TR-AREMSv1S-AIREnzyme immunoassay for the qualitative determination of antibodies to Infliximab Remsima in serum and plasma.
TR-AREMSv2S-AIREnzyme immunoassay for the quantitative determination of antibodies to Infliximab Remsima in serum and plasma.
TR-AREMSv3S-AIREnzyme immunoassay for the semi-quantitative determination (screening) of total antibodies to Infliximab biosimilar (Remsima®) in serum and plasma.
TR-QDENv1Q-DENEnzyme immunoassay for the quantitative determination of Denosumab (Prolia®)in serum and plasma.
TR-AATDv1S-ATDEnzyme immunoassay for the qualitative determination of antibodies to Denosumab in serum and plasma.
TR-OMAv1Q-OMAEnzyme immunoassay for the quantitative determination of Omalizumab (Xolair®) Remsima in serum and plasma.
TR-AATOv1S-ATOEnzyme immunoassay for the qualitative determination of antibodies to Omalizumab in serum and plasma.
TR-Q-NIVOv1Q-NIVOEnzyme immunoassay for the quantitative determination of Nivolumab (Opdivo®) in serum and plasma.
TR-ATNv1S-ATNEnzyme immunoassay for the qualitative determination of antibodies to Nivolumab in serum and plasma.
TR-PEMv1Q-PEMEnzyme immunoassay for the quantitative determination of Pembrolizumab (Keytruda®) in serum and plasma.
TR-A-PEMv1S-ATPEnzyme immunoassay for the qualitative determination of antibodies to Pembrolizumab in serum and plasma.
TR-AFAv1Q-AFAEnzyme immunoassay for the quantitative determination of specific anibodies to Filgrastim in serum and plasma.
TR-IPIv1Q-IPIEnzyme immunoassay for the quantitative determination of specific Ipilimumab(Yervoy®) in human serum and plasma.
TR-AIPIv1S-ATIEnzyme immunoassay for the qualitative determination of specific anibodies to Ipilimumab in serum and plasma.
TR-Q-AVEv1Q-AVEEnzyme immunoassay for the quantitative determination of specific Avelumab(Bavencio®) in human serum and plasma.
TR-A-AVEv1S-ATAVEnzyme immunoassay for the qualitative determination of specific anibodies to Avelumab in serum and plasma.
TR-RANv1Q-RANEnzyme immunoassay for the quantitative determination of free Ranibizumab in aqueous humour.
TR-RAMv1Q-RAMEnzyme immunoassay for the quantitative determination of free Ramucirumab in serum and plasma.
TR-ARAMv1S-ATRAMEnzyme immunoassay for the qualitative determination of antibodies to Ramucirumab in serum and plasma.
TR-CERTv2Q-CERTEnzyme immunoassay for the quantitative determination of Certolizumab in human serum and plasma
TR-Q-VEDOv1Q-VEDOEnzyme immunoassay for the quantitative determination of Vedolizumab in human serum and plasma
TR-ATVv1S-ATVEnzyme immunoassay for the qualitative determination of antibodies to Vedolizumab in human serum and plasma
TR-Q-USTv1Q-USTEnzyme immunoassay for the quantitative determination of Ustekinumab in human serum and plasma
TR-AUSTv1S-ATUEnzyme immunoassay for the qualitative determination of antibodies to Ustekinumab in human serum and plasma
 

如果你對MatriksBiotek品牌產(chǎn)品列表介紹感興趣,想了解更詳細(xì)的產(chǎn)品信息,填寫下表直接與廠家聯(lián)系:

留言框

  • 產(chǎn)品:

  • 您的單位:

  • 您的姓名:

  • 聯(lián)系電話:

  • 常用郵箱:

  • 省份:

  • 詳細(xì)地址:

  • 補充說明:

  • 驗證碼:

    請輸入計算結(jié)果(填寫阿拉伯?dāng)?shù)字),如:三加四=7
版權(quán)所有 © 2024 蘇州螞蟻淘生物科技有限公司  ICP備案號:蘇ICP備17049038號-2
在線留言 聯(lián)系方式 二維碼

服務(wù)熱線

18915418616

掃一掃,關(guān)注我們